These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3301443)

  • 1. Insulin resistance in maturity onset diabetes of the young.
    Mohan V; Sharp PS; Aber VR; Mather HM; Kohner EM
    Diabete Metab; 1987 Jun; 13(3):193-7. PubMed ID: 3301443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of obesity on insulin action in NIDDM.
    Campbell PJ; Carlson MG
    Diabetes; 1993 Mar; 42(3):405-10. PubMed ID: 8432411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in Fibrocalculous (tropical) pancreatic diabetes.
    Mohan V; Ramachandran A; Vijay Kumar G; Snehalatha C; Viswanathan M
    Horm Metab Res; 1988 Dec; 20(12):746-8. PubMed ID: 3220451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic abnormalities in offspring of NIDDM patients with a family history of diabetes mellitus.
    Migdalis IN; Zachariadis D; Kalogeropoulou K; Nounopoulos C; Bouloukos A; Samartzis M
    Diabet Med; 1996 May; 13(5):434-40. PubMed ID: 8737025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sensitivity to insulin in type I diabetes. Preliminary report].
    Pernet A; Kuntschen F; Trimble ER; Assal JP; Hahn C; Renold AE
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1917-9. PubMed ID: 6364337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyper insulinism and decreased insulin sensitivity in nonobese healthy offspring of conjugal diabetic parents and individuals with IGT and NIDDM.
    Rao CA; Snehalatha C
    Indian J Physiol Pharmacol; 1996 Apr; 40(2):139-44. PubMed ID: 9062808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.
    Taniguchi A; Fukushima M; Sakai M; Kataoka K; Nagata I; Doi K; Arakawa H; Nagasaka S; Tokuyama K; Nakai Y
    Metabolism; 2000 Aug; 49(8):1001-5. PubMed ID: 10954017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The euglycemic clamp technique in patients with liver cirrhosis.
    Vannini P; Forlani G; Marchesini G; Ciavarella A; Zoli M; Pisi E
    Horm Metab Res; 1984 Jul; 16(7):341-3. PubMed ID: 6386642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree.
    Herman WH; Fajans SS; Ortiz FJ; Smith MJ; Sturis J; Bell GI; Polonsky KS; Halter JB
    Diabetes; 1994 Jan; 43(1):40-6. PubMed ID: 8262315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity within type II and MODY diabetes.
    Fajans SS
    Adv Exp Med Biol; 1985; 189():65-87. PubMed ID: 3898767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance in patients of Asian Indian and European origin with non-insulin dependent diabetes.
    Sharp PS; Mohan V; Levy JC; Mather HM; Kohner EM
    Horm Metab Res; 1987 Feb; 19(2):84-5. PubMed ID: 3549505
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and metabolic characterization and therapy goal of non-insulin-dependent (Type II) diabetes mellitus].
    Ratzmann KP
    Z Arztl Fortbild (Jena); 1990; 84(21):1075-7. PubMed ID: 2281689
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans. Assessment in absence of artifact introduced by tritiated nonglucose contaminants.
    Butler PC; Kryshak EJ; Schwenk WF; Haymond MW; Rizza RA
    Diabetes; 1990 Feb; 39(2):217-25. PubMed ID: 2227130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin antagonism is not a primary abnormality of amyotrophic lateral sclerois but is related to disease severity.
    Harris MD; Davidson MB; Rosenberg CS
    J Clin Endocrinol Metab; 1986 Jul; 63(1):41-6. PubMed ID: 3519649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relations between plasma insulin and biliary calculosis in diabetic patients].
    Caroli A; Sardeo G; Gasparoni P; Volpi A; Cecchetto G; Piaserico GP
    Minerva Dietol Gastroenterol; 1988; 34(3):205-8. PubMed ID: 3059232
    [No Abstract]   [Full Text] [Related]  

  • 18. Maturity-onset diabetes of the young (MODY).
    Fajans SS
    Diabetes Metab Rev; 1989 Nov; 5(7):579-606. PubMed ID: 2689121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for insulin resistance in Indian patients with non-insulin dependent diabetes in the young.
    Jialal I; Naidoo C; Rajput M; Joubert SM
    Horm Metab Res; 1984 Jul; 16(7):377-8. PubMed ID: 6489923
    [No Abstract]   [Full Text] [Related]  

  • 20. Both glucagon excess and insulin deficiency characterize maturity-onset diabetes mellitus of youth (MODY).
    AvRuskin TW; Obilessetty V; Jabbar M; Prasad V; Greenfield E; Greig F; Juan CS
    J Pediatr Endocrinol; 1994; 7(4):335-41. PubMed ID: 7735372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.